Products | CivicaScript | Generic and biosimilar medicines available now

Products

Available generic and biosimilar medicines

Currently Available

MaxRP™

Abirtega (abiraterone), 250 mg: 120 tablets

$141

Abiraterone, 250 mg: 120 tablets

$141

Capecitabine, 150 mg: 60 film-coated tablets

Capecitabine, 500 mg: 120 film-coated tablets

Civica insulin glargine-ygfn, prefilled for box of 5 prefilled pens

Dalfampridine, 10 mg: 60 extended-release tablets (1-month supply)

Dimethyl fumarate, 120 mg: 14 capsules

Dimethyl fumarate, 240 mg: 60 capsules

Droxidopa, 100 mg: 90 capsules

Droxidopa, 200 mg: 90 capsules

$109

Droxidopa, 300 mg: 90 capsules

$153

Ustekinumab-aauz, 45 mg

$625

Ustekinumab-aauz, 90 mg

$1,035

For questions about filling a prescription, contact us >
For Civica insulin glargine-yfgn patient information, click here >

WITH MORE TO COME

As membership grows, more medications will become available. Learn more about membership >

MaxRP™

CivicaScript’s MaxRP™ policy is our maximum recommended price to the consumer.

Information on every CivicaScript product label enables healthcare providers, caregivers, patients and others to compare prices and confirm they are being charged no more than the MaxRP.

THE CIVICA
INSULIN INITIATIVE

CivicaScript is working with Civica and numerous partners to bring affordable biosimilar insulin to market.

Read more here >

Adverse events

For adverse event reporting, product quality complaints or medical information, please call CivicaScript at 1-833-224-2004 or the FDA at 1-800-FDA-1088 or visit fda.gov/medwatch.

Returns

Learn about CivicaScript’s Customer Product Returns Policy here >

CivicaScript model delivers significant patient and payer savings. Learn more >

Available generic and biosimilar medicines

WITH MORE TO COME

THE CIVICA INSULIN INITIATIVE

Adverse events

Returns

THE CIVICA
INSULIN INITIATIVE